The effects of atropine-oxime therapy on cholinesterase activity and the survival of animals poisoned with O,O-diethyl-O-(2-isopropyl-6-methyl-4-pyrimidinyl) phosphorothioate.
D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D001774:Blood Chemical Analysis; D001923:Brain Chemistry; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D002802:Cholinesterases / Q000378:metabolism*; D003964:Diaphragm / Q000032:analysis; D005260:Female; D010756:Phosphoric Acids / Q000633:toxicity*; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D010756:Phosphoric Acids; D011220:Pralidoxime Compounds; D001285:Atropine; D002802:Cholinesterases